[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Hohl et al., 2023 - Google Patents

Gynecomastia

Hohl et al., 2023

Document ID
15965893456110522489
Author
Hohl A
Ronsoni M
van de Sande Lee S
Publication year
Publication venue
Testosterone: From Basic to Clinical Aspects

External Links

Snippet

Gynecomastia is a benign proliferation of glandular tissue in the male breast. It can be unilateral or, more commonly, bilateral and often asymmetrical (Billa et al., Andrology 9: 1444, 2021). A recent study observed a 32.3% prevalence of gynecomastia among 1877 …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Similar Documents

Publication Publication Date Title
Kanakis et al. EAA clinical practice guidelines—gynecomastia evaluation and management
Meeta et al. Clinical practice guidelines on menopause:* An executive summary and recommendations: Indian Menopause Society 2019–2020
Bianchi et al. The role of androgens in women's health and wellbeing
Laudisio et al. Obesity and breast cancer in premenopausal women: Current evidence and future perspectives
Baber et al. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Blondell et al. Disorders of puberty
Kotsopoulos et al. Androgens and breast cancer
Hänggi et al. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women
Tan et al. An integrative review on current evidence of testosterone replacement therapy for the andropause
Schulman et al. The ageing male
Miller Androgen deficiency: effects on body composition
Goss et al. Longitudinal associations of the endocrine environment on fat partitioning in postmenopausal women
Han et al. Fate of the micropenis and constitutional small penis: do they grow to normalcy in puberty?
Banerjee et al. Precocious puberty
Nieschlag et al. Clinical uses of testosterone in hypogonadism and other conditions
Hohl et al. Gynecomastia
Kaplowitz Precocious puberty: update on secular trends, definitions, diagnosis, and treatment
Roeca et al. The postmenopausal women
Kaplowitz Update on precocious puberty: girls are showing signs of puberty earlier, but most do not require treatment
Franklin et al. Precocious puberty secondary to topical testosterone exposure
Pyra et al. Puberty: normal, delayed, and precocious
Chan et al. Assessment and management of male androgen disorders: an update
Kaplowitz Precocious puberty
Schwartz et al. Hormones in wellness and disease prevention: common practices, current state of the evidence, and questions for the future
Singer-Granick et al. Gynecomastia what the surgeon needs to know